Antibacterial Agents TRIZ Cases

Targeting MqnE enzymes in the futalosine pathway selectively inhibits Campylobacter growth while preserving gut microbiome integrity.

Inhaled GM-CSF stimulates lung immune responses to reduce bacterial load while avoiding antibiotic side effects.

A microemulsion formulation prevents self-assembled aggregates from forming.

Zinc ions and chitosan cross-link alginate to prevent aggregation while controlling pore size for food-safe encapsulation.

O-carbonyl phosphoramidate prodrugs improve water solubility through nitrogen-phosphorus bond cleavage, enabling stable liquid formulations.

Hydrocarbon-linked mannose derivatives resist glycosidase hydrolysis and acidic degradation while binding FimH adhesin.

Antibiotics reduce abnormal vaginal microbiota before introducing Lactobacillus species to restore a healthy environment and improve IVF success rates.

An SCR-Ab construct combines a pathogen-specific antibody with a complement factor H-derived short consensus repeat to target microbial surfaces.

Modified tetra-branched peptide sequences eliminate spontaneous pyroglutamic acid formation to ensure batch homogeneity and protease resistance.

Lactococcus lactis strains secrete peptidoglycan hydrolase enzymes to disrupt pathogenic bacterial cell walls.

Lactylate esters replace traditional lactic acid to reduce intestinal infections from gram-positive bacteria without triggering antibiotic resistance.

Segmented purification and freeze-drying stabilize fecal samples to treat drug-resistant infections.

Tetanus toxoid carrier protein enables meningococcal conjugate vaccines to elicit robust antibody responses in pre-immunized patients.

Oral carboxylic acid mixture captures ammonium ions to reduce urea concentrations, avoiding expensive dialysis and improving nitrogen balance.

Administering allogeneic activated T-cells to stimulate patient antigen-presenting cells for systemic endogenous IL-12 production.

Castanea sativa extracts containing castalagin and vescalagin inhibit Helicobacter pylori growth and reduce gastric inflammation without antibiotic resistance.

Low-temperature iodination in a chloride-free solvent prevents transhalogenation impurities during rose bengal production.

Als3p polypeptide vaccine elicits robust immune response in mammals.

Genetically modified Yersinia bacteria produce outer membrane vesicles containing MPLA adjuvant and LcrV antigen for robust immune response.

Segmenting gp130 into domains 1 to 3 eliminates aggregation while maintaining binding affinity for IL-6/sIL-6R complexes.

DVD binding proteins utilize specific linker sequences to achieve high-affinity binding while reducing molecular heterogeneity and immunogenicity.

Probiotic vesicles deliver therapeutic agents via intermediary carriers, preventing bacterial resistance while preserving intestinal microbiota balance.

Replacing poorly immunogenic capsular polysaccharides with conserved protein antigens overcomes molecular mimicry and strain variation in MenB vaccines.

Siderophore-polymer conjugates bypass impermeable outer membranes to restore antibiotic sensitivity in resistant Pseudomonas aeruginosa.

Microencapsulating probiotic bacteria within film-forming protein and carbohydrate matrices creates stable powders for targeted gut delivery.

Bispecific antibody binds distinct tetanus toxin epitopes to achieve potent neutralization.

Fatty acid amide coupling extends peptide half-life, resolving rapid metabolism bottlenecks in cardiovascular therapy.

A preservative-free multidose ophthalmic dispenser delivers multiple active pharmaceutical ingredients through a single squeeze bottle.

Novel 3-cyano 4,5-diphenyl furan-2-carboxamides bypass existing resistance mechanisms to treat multidrug-resistant strains.

Probiotic strains with N-acetylcysteine and lysozyme dissolve biofilms and prevent spore germination to combat resistant pathogens.

Immunogenic composition targets conserved proteins ABC-T, PavA, and ZmpB to induce robust immune responses across diverse pneumococcal strains.

Andrographolide triggers endogenous beta-defensin 3 production, bypassing complex exogenous synthesis costs while delivering broad-spectrum pathogen resistance.

A platinum-based adduct acts as a photoinitiator and photocrosslinker to facilitate hydrogelation and protein labeling.

Conjugating bacitracin with alginate oligomers overcomes limited Gram-negative efficacy and host toxicity by creating hybrid molecules with enhanced activity.

Topical probiotic lysate application enhances keratinocyte barrier function and accelerates wound recovery.

Segmented single-chain structures with Fc moieties prevent multimerization and generalized inflammation while extending in vivo persistence.

A foamable iodine composition forms a breakable aerated structure with specific gravity between 0.02 and 0.35 g/ml.

Antibodies targeting first and second CCR2 extracellular loops block MCP-1-induced chemotaxis for inflammatory disease treatment.

Pyrazolopyridine derivatives inhibit Janus kinases locally in the lung to reduce systemic side effects.

Larval gut extract reduces silver nitrate into 45-90 nm nanoparticles, eliminating toxic by-products from conventional synthesis.